PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15682260

Interrelationship between thyroid nodularity and TSH level.

Isaac Sachmechi·Marjan Vahedi·Shireesha Nalamasu·Raj Vuppalanchi
View original source ↗Export metadata ↓

Abstract

BACKGROUND: The pathophysiological role of thyroid-stimulating hormone (TSH) in the development of goiter is controversial. The aim of this study was to examine the relationship between thyroid nodularity and serum TSH levels in clinically and biochemically euthyroid patients with non-endemic multinodular goiter. METHODS: We surveyed 44 of our endocrine clinic patients with multinodular goiter. Twenty-five patients with suppressed TSH levels or positive antithyroid antibodies were excluded. The remaining 19 patients were included (group 1). The 19 study subjects were compared with 19 age- and sex- matched controls without any thyroid disease or goiter (group 2). TSH levels in both groups were checked by review of their medical records. RESULTS: In group 1, TSH ranged from 0.68-3.68 IU/mL (normal: 0.4-6.0 IU/mL), with a mean of 1.45 +/- 0.29. In group 2, TSH ranged from 0.38-1.88 IU/mL, with a mean of 1.08 +/- 0.1. The differences of these values, analyzed by paired t test (p=0.22), were not statistically significant. CONCLUSIONS: These data suggest that TSH levels in euthyroid patients with multinodular goiter are not significantly different from those in normal controls.

Explore related subjects

Case-Control StudiesFemaleGoiter, NodularHumansMaleRetrospective StudiesThyroid Function TestsThyroid GlandThyroid NoduleThyrotropinJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Isaac Sachmechi, Marjan Vahedi, Shireesha Nalamasu, Raj Vuppalanchi. 2005. Interrelationship between thyroid nodularity and TSH level.. https://pubmed.ncbi.nlm.nih.gov/15682260/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Accurate and efficient power calculations for 2 x m tables in unmatched case-control designs.

The aim of this article was to derive an approximation of the distribution of Pearson's statistic for 2 x m contingency tables to calculate power for case-control studies accurately and efficiently in terms of computer time. We first prove that, rather than a non-central chi-square distribution, Pearson's statistic is asymptotically equivalent with the sum of squares of m independent normal random variables whose variances are typically different under the alternative hypothesis. Based on this asymptotically equivalent (AE) we derive a cost-effective approximation (CE). Numerical results show that CE was almost as precise as AE, but computationally more efficient. Although somewhat less costly in terms of CPU time, we show that a commonly used approximation using the non-central chi-square distribution can be very inaccurate and overestimate power in some scenarios and underestimate it in others. Simulations and exact distributions, on the other hand, are accurate but computationally very intensive compared to our CE. The CE reached its lowest accuracy under the null hypothesis where it has a chi-square distribution with m - 1 degree of freedom. This suggests that CE can be used to calculate power for tables where researchers would feel comfortable using Pearson's chi-square test.

Case-Control Studies↗
PubMed2005

COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study.

This is the first study of a possible molecular genetic basis for schizophrenia with obsessive-compulsive disorder (OCD). We performed a case-control association study of the catechol-O-methyltransferase (COMT) Val158Met polymorphism in schizophrenia-OCD patients, OCD and healthy controls. One hundred and thirteen schizophrenia-OCD patients, 79 OCD patients and 171 control subjects were genotyped for the Val(158)Met polymorphism in the COMT gene. There was no significant difference in allele and genotype distribution of the COMT gene between schizophrenia-OCD patients and healthy controls. The low-activity Met allele and Met/Met genotype were more frequent in OCD men than in schizophrenia-OCD and control individuals. This difference, however, was not statistically significant following correction for multiple comparisons. These results do not support the hypothesis that the COMT Val158Met gene polymorphism is associated with liability to schizophrenia-OCD.

Case-Control Studies↗